Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
Key Details
- 1VIS-Fbs only emit fluorescence when bound to their target, reducing background by up to 100-fold.
- 2The technology allows tracking of multiple cellular targets simultaneously across the visible spectrum.
- 3Validated in various mammalian cells, neurons, astrocytes in mice, and zebrafish models.
- 4Certain VIS-Fbs are photo-switchable, supporting high spatial and temporal imaging precision.
- 5Published in Nature Methods; supported by multiple major biomedical funding bodies.
Why It Matters
VIS-Fb probes offer a major advance for live-cell and tissue imaging accuracy, enabling real-time, high-contrast visualization of molecular processes in complex biological systems. This innovation could improve fundamental research and precision imaging applications, including those relevant to disease modeling and radiology AI integration.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.